why choose us

First received: November 17, 2023

Clinical Trial: Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hypertension

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

Brief Summary: This is a Phase 3 trial to evaluate the BP-lowering effect of lorundrostat (an aldosterone synthase inhibitor) in subjects with uncontrolled and resistant hypertension taking between 2 and 5 anti-hypertensive (AHT) medications.

Read more